Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Potassium substitutes during tocolysis].

W Wiest, H Weidinger, W D Hiltmann

    Fortschritte Der Medizin
    |February 19, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Not Available].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
    Same author

    [Not Available].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
    Same author

    [Not Available].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
    Same author

    Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Optimizing the pharmacotherapy of vascular surgery patients by medication reconciliation.

    The Journal of cardiovascular surgery·2014
    Same author

    Dynamic cystocolpoproctography is superior to functional pelvic MRI in the diagnosis of posterior pelvic floor disorders: results of a prospective study.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2014
    Same journal

    [More information--less pain. Procedure in pain following amputation of limbs. Brachial plexus injury and nerve root avulsion. Interview by Susanne Kammerer].

    Fortschritte der Medizin·1999
    Same journal

    [Galenic alternatives to unstable tocopherol acetate. "Smeared" or cheated?--Vitamin E in facial ointments].

    Fortschritte der Medizin·1999
    Same journal

    [Gene diagnosis in the hand of the physician].

    Fortschritte der Medizin·1999
    Same journal

    [Is non-toxic cancer therapy through biotechnology a possibility?].

    Fortschritte der Medizin·1999
    Same journal

    [Smoking withdrawal in practice and clinic].

    Fortschritte der Medizin·1999
    Same journal

    [The future of pancreas diagnosis. An exclusive training service of the Gastro-Ligue for dermatologists].

    Fortschritte der Medizin·1999
    See all related articles

    Serum potassium levels drop during tokolytic therapy with Partusisten and Isoptin within 24 hours. While levels normalize in 48 hours, initial drops require potassium substitution to prevent hypokalemia.

    Area of Science:

    • Obstetrics and Gynecology
    • Clinical Pharmacology
    • Cardiology

    Context:

    • Tokolytic therapy is used to inhibit premature uterine contractions.
    • Partusisten (fenoterol) and Isoptin (verapamil) are commonly used tocolytic agents.
    • Hypokalemia, a potential side effect of tocolytic therapy, can affect cardiac function.

    Purpose:

    • To investigate the changes in serum potassium levels during tokolytic therapy.
    • To determine the cause of potassium decrease during tocolysis.
    • To assess the clinical significance of serum potassium changes and the need for supplementation.

    Summary:

    • Serum potassium levels significantly decrease within the first 24 hours of tokolytic therapy using Partusisten and Isoptin.
    • This decrease is not attributed to increased renal potassium excretion.

    Related Experiment Videos

  • Electrocardiogram changes indicative of hypokalemia are observed, but serum potassium levels and ECG findings normalize within 48 hours without intervention.

    • Impact:

    • The initial drop in serum potassium during tocolysis necessitates potassium substitution to prevent potential cardiac complications associated with hypokalemia.
    • Understanding potassium dynamics during tocolysis can guide clinical management and improve patient safety.
    • This study highlights the importance of monitoring electrolytes and considering supplementation during extended tocolytic treatment.